Zvinetso zveTroroid Mushonga Wezvinodhaka Murairo Mylan

Kana uri kutsvakurudza ma generic levothyroxine uye liothyronine mishonga yekurapa thy hypothyroidism, unogona kunzwa pamusoro peSudan uye Drug Administration (FDA) kuongorora kuMylan. Mylan ndiyo yechitatu yekurisa zvinodhaka, uye inogadzirwa ne generic levothyroxine uye liothyronine, iyo inogadzirwa zvechirwere Cytomel . Mishonga yose iyo utachiona hormone mishonga yemishonga inoshandiswa kugadzirisa hypothyroidism.

Muzhizha ra 2009, FDA yakavhura kuongorora, asi mukati memavhiki mashomanana, upfumi hwakanga hwavharwa, uye kwakanga kusina uchapupu hwokuti hutano hweMylan-made, hunosanganisira levothyroxine, hwakavhiringidzika.

Heino humwe ruzivo rwaunoda kuziva kuti uite chisarudzo chakanaka pamusoro pemishonga iyi.

Nhoroondo

Muna 2009, West Virginia-based Mylan yakanga iri hurukuro yehurumende kuongorora zvinetso zvekugadzira pamiti yavo. Gwaro rePittsburgh Post rakabvarura nyaya yevashandi paMylan's West Virginia plant, avo vakanga vari, maererano nemagwaro emukati akawanikwa nePost-Gazette , "nguva dzose pamusoro pemakombiyuta akabudiswa pamusoro pezvinetso zvingangodaro nemishonga yavaiita."

Panguva iyoyo, FDA yakataura kuti Mylan aibatanidzwa mukunyengera ruzivo uye kuchinja michina, zvichida kwenguva refu semakore maviri kana kupfuura. Mushure mokunge FDA yakazarura kuongororwa kuMylan, kambani yakabudisa chirevo chinoratidza kuti FDA tsvakurudzo yaive tsika.

Asi FDA, zvisinei, yakatora danho risina kujairika rekubudisa chirevo kuti ripikise uye rambazve kuedza kweMylan kuderedza kuoma kwepfungwa.

Pakazoongororwa upfumi, Pittsburgh Post-Gazette yakaparidzira zvakadzama mamiriro ezvinhu eMylan, kusanganisira nyaya dzinotevera:

Mushure memavhiki akawanda apo Mylan ematengo ematokari akadonha, uye Mylan naDDA vakaita hondo yevanhu vose mumashoko ekudhinda. Mylan akatsigirawo vatori venhau vePittsburgh Post, avo vakaputsa nyaya yekutsauka.

Dhiyabhorosi akazobvisa Mylan, achiita chiziviso musi waAugust 13, 2009. Maererano neDFA, Mylan akanga aita sarudzo yakakwana, mutauriri wesangano, uye FDA yakavhara upfumi.

VaMylan vanopomerwa mhosva yepanhau rakagadziriswa muna 2012, uye Mylan uye Post-Gazette vakabudisa chirevo chakati, chikamu:

Kutongwa kwacho kwakagadziriswa kusvika kugutsikana kwevaviri. I Post-Gazette haina kuwana uye yakanga isingadi kurondedzera kuti Mylan akanga agadzira kana kuparadzira chero mishonga isina kukwana.

Shoko kubva

Izvo zvakashata zvechiitiko ichi kune varwere vehutachiona ndechokuti kwakanga kusina uchapupu hwekuti hutano hwezvinodhaka hwakaitwa naMylan, kusanganisira levothyroxine uye liothyronine zvinodhaka zvakatorwa nevanhu vazhinji vane hypothyroidism, zvakabatwa nenzira ipi zvayo.

Panguva imwecheteyo, vanhu vane hypothyroidism vanotora utachiona hwemishonga yemishonga inonzi levothyroxine vanofanira kuziva kuti vanachiremba vakawanda HAVATATI kuti chirwere chetachiona chinotora chero generic levothyroxine kubva kune chero yakagadzira. Chikonzero chacho ndechokuti zvose levothyroxine zvinodhaka, kusanganisira mazita emagetsi uye mazita emishonga, zvinotenderwa zviri pamutemo kuti zviparadzanise mu potency kubva ku 95 kusvika ku 105 muzana yemutero wakatarwa. Paunotora levothyroxine generic, zvinogadziriswa zvinogona kubva kune chero mhizha, izvo zvinoreva kuti imwe neimwe yekudzokorora dhigirii inogona kuwira chero kupi mukati mechiratidzo ichocho.

Kunyange kupesana kuduku mu potency kunogona kupesana nekubudirira kwetachiona yako hormone replacement.

Yakagadzirirwa utachiona hormone inoshandiswa inonyanya kukoshawo kune vanopukunyuka chirwere chetachiona, avo vanogona kudiwa nguva dzose vachideredza utachiona hunokurudzira hormone (TSH) maitiro sechikamu chekurapa kwavo, uye kudzivirira kudzokorora kenza yekenza.

Kana uri kutora levothyroxine generic kubva kune umwe mugadziri, zvinobatsira kukurukura nemamiriro ako ezvinhu nemutano wako wehutano, kuti uone kana zita rezita remishonga raizova rakanakisisa pane kurapa kwako.